
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[TXG] 10x Genomics Inc - Cl. A Cashflow Statement
Data updated 2024-Mar-24 (Sunday)Note: Easy to read Cashflow Statement for 10x Genomics Inc - Cl. A [NASDAQ:TXG] with charts that analyze trends of statement items & metrics and compare them with peers
Share
View Financial Statements & visualize data for other stocks
Choose statement type
Choose statement frequency
Annual Cashflow Statement values for 10x Genomics Inc - Cl. A are rounded to enhance readability. Hover on cells below for additional contextual info. Key metrics are also provided for your convenience
2023-Dec | 2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | |
---|---|---|---|---|---|---|
Net Income Detail | -255 M | -166 M | -166 M | -58.2 M | -543 M | -31.3 M |
Depreciation & Amortization Detail | 35.5 M | 33 M | 33 M | 28.3 M | 19 M | 7.07 M |
Taxes Detail | - | - | - | - | - | - |
Working Capital Detail | -8.76 M | -39.4 M | -33 M | -85 M | -45.5 M | 44.8 M |
Other Operating Detail | 213 M | 139 M | 139 M | 96 M | 356 M | 14 M |
Operating Cash Flow Detail | -15.2 M | -33.6 M | -27.2 M | -18.9 M | -213 M | 34.6 M |
Operating Cash Flow / Sales Detail | -2.5% | -6.5% | -5.3% | -3.9% | -71.3% | 14.1% |
Cash EPS Detail | -0.13 | -0.3 | -0.24 | -0.17 | -2.11 | 0.36 |
Capital Expenditure Detail | -48.6 M | -132 M | -132 M | -101 M | -38.4 M | -42.8 M |
Investments Detail | 183 M | -215 M | -215 M | - | - | - |
Acquisitions Detail | - | -4 M | -4 M | -5.45 M | - | - |
Other Investing Detail | -923 K | - | - | - | - | - |
Investing Cash Flow Detail | 133 M | -351 M | -351 M | -107 M | -38.4 M | -42.8 M |
Investing Cash Flow / Sales Detail | 21.6% | -68.0% | -68.0% | -21.8% | -12.9% | -17.4% |
Dividend Detail | - | - | - | - | - | - |
Stock Detail | - | 21.2 M | 21.2 M | 40.3 M | 506 M | 415 M |
Debt Detail | - | -5.41 M | -11.8 M | -7.5 M | -41.9 M | -773 K |
Other Financing Detail | 13.7 M | - | - | - | - | 773 K |
Financing Cash Flow Detail | 13.7 M | 15.8 M | 9.39 M | 32.8 M | 464 M | 415 M |
Financing Cash Flow / Sales Detail | 2.2% | 3.1% | 1.8% | 6.7% | 155.3% | 168.6% |
Net Change in Cash Detail | 132 M | -369 M | -369 M | -92.6 M | 212 M | 406 M |
Free Cash Flow Detail | 33.4 M | -165 M | -159 M | -120 M | -250 M | -8.12 M |
FCF / Share Detail | 0.29 | -1.45 | -1.4 | -1.09 | -2.47 | -0.08 |
Chart shows absolute values of Net Income using annual statements for 10x Genomics Inc - Cl. A. Fiscal Dates standardized to enable peer comparisons
Select Cashflow Statement line/metric for chart. Other fields & statement line items available when different statement type selected
Subsequent stock performance post annual earnings date till next announcement for 10x Genomics Inc - Cl. A. Dates correspond to earnings announcement dates for the period when new financial data became available to the market. Prices have been adjusted for any splits
Related to 10x Genomics Inc - Cl. A
Information for 10x Genomics Inc - Cl. A
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-05 on Google
SEC Reports : Quarterly reports around 2025-May-05 on SEC Edgar
Compare 10x Genomics Inc - Cl. A with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes 10x Genomics Inc - Cl. A
Industry : Equipment & Supplies industry performance which includes 10x Genomics Inc - Cl. A